Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Bio-Techne Corporation (TECH) and Cutera (CUTR)


Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jazz Pharmaceuticals (NASDAQ:JAZZ), Bio-Techne Corporation (NASDAQ:TECH) and Cutera (NASDAQ:CUTR).

Jazz Pharmaceuticals (JAZZ)

In a report released yesterday, Corey Davis from Seaport Global reiterated a Buy rating on Jazz Pharmaceuticals, with a price target of $207. The company’s shares closed yesterday at $175.58, close to its 52-week high of $184.

According to TipRanks.com, Davis is a 2-star analyst with an average return of 0.2% and a 41.7% success rate. Davis covers the Healthcare sector, focusing on stocks such as Pacira Pharmaceuticals, Infinity Pharma, and Omeros Corp.

Jazz Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $205.50, representing a 17.0% upside. In a report released yesterday, BMO Capital also maintained a Buy rating on the stock with a $206 price target.

.

See today’s analyst top recommended stocks >>

Bio-Techne Corporation (TECH)

In a report released yesterday, Drew Jones from Stephens reiterated a Hold rating on Bio-Techne Corporation, with a price target of $180. The company’s shares closed yesterday at $177.32, close to its 52-week high of $183.90.

According to TipRanks.com, Jones is a 4-star analyst with an average return of 16.2% and a 64.2% success rate. Jones covers the Healthcare sector, focusing on stocks such as Orasure Technologies, Ligand Pharma, and Repligen Corp.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bio-Techne Corporation with a $187.67 average price target.

Cutera (CUTR)

In a report released yesterday, Chris Cooley from Stephens reiterated a Buy rating on Cutera, with a price target of $50. The company’s shares closed yesterday at $34.03, close to its 52-week low of $30.70.

According to TipRanks.com, Cooley is a 5-star analyst with an average return of 34.4% and a 75.0% success rate. Cooley covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Staar Surgical Company, and DENTSPLY SIRONA Inc.

Cutera has an analyst consensus of Hold.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts